GINKGO BIOWORKS HOLDINGS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings of -$2.42 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 · last filed 2024-02-29
- GINKGO BIOWORKS HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2023 was -$2.42M, a 442.70% decline from fiscal 2022.
- GINKGO BIOWORKS HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2022 was $705.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 12 month |
|---|---|
| 2023-12-31 | -$2.42M 10-K · filed 2024-02-29 |
| 2022-12-31 | $705.00K 10-K · filed 2024-02-29 |